Article Text

other Versions

Download PDFPDF
Systematic review with meta-analysis
Use of real-time continuous glucose monitoring versus traditional self-monitoring of blood glucose levels improves glycaemic control in patients with type 1 diabetes
  1. Cynthia Fritschi
  1. Biobehavioral Health Sciences, University of Illinois, Chicago, Illinois, USA
  1. Correspondence to Cynthia Fritschi
    Biobehavioral Health Sciences, University of Illinois, 845 South Damen M/C 802, Chicago, IL 60612, USA; fritschi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text

Implications for nursing practice and research

  • Use of real-time continuous blood glucose monitoring (RT-CGM) as part of treatment of type 1 diabetes results in decreased HbA1c levels when compared with self-monitoring of blood glucose (SMBG).

  • The improvement in glycaemic control with RT-CGM use was especially pronounced in patients with poorer glycaemic control and in those who used the technology more frequently.

  • Use of RT-CGM may decrease exposure to hypoglycaemia in some patients.

  • This model is able to predict cost-effectiveness of RT-CGM in the clinical setting based on glycaemic control, sensor usage and age of patient.


In patients with type 1 diabetes (T1DM), tight glycaemic control is associated with profound reductions in risks for …

View Full Text


  • Competing interests None.